Hong Kong Stock Movement | Keymed Biosciences-B (02162.HK) Rises Over 6% in Afternoon Session; Kangyueda Approved for Marketing for Adolescent Atopic Dermatitis Indication

Zhitong Finance APP has learned that Keymed Biosciences-B (02162.HK) rose more than 6% in the afternoon. As of press time, it was up 4.45% at HK$85.4, with a turnover of HK$187 million.